Literature DB >> 13345963

The amino acid composition of hypertensin II and its biochemical relationship to hypertensin I.

K E LENTZ, L T SKEGGS, K R WOODS, J R KAHN, N P SHUMWAY.   

Abstract

Preparations of hypertensin II, obtained from the treatment of hypertensin I by the action of the hypertensin converting enzyme of plasma and purified by countercurrent distribution, were quantitatively analyzed for their amino acid content. Chromatography on ion exchange columns showed the presence of equimolar amounts of aspartic acid, proline, valine, isoleucine, tyrosine, phenylalanine, histidine, and arginine. Hypertensin I was found to contain one mole of leucine and one mole of histidine in addition to the amino acids of hypertensin II. These two amino acids were isolated from the conversion products of hypertensin I and identified as the peptide histidylleucine. Carboxypeptidase digestion of hypertensin I showed the carboxyl terminal sequence of amino acids to be residue-phenylalanyl-histidylleucine. Similar studies of hypertensin II demonstrated residue-phenylalanine. It was concluded that the conversion of hypertensin I by the plasma hypertensin converting enzyme involved hydrolysis of the phenylalanyl-histidine bond to form hypertensin II and histidylleucine. The further removal by carboxypeptidase of phenylalanine from hypertensin II destroyed all of the vasoconstrictor activity.

Entities:  

Keywords:  AMINO ACIDS/determination; ANGIOTONIN

Mesh:

Substances:

Year:  1956        PMID: 13345963      PMCID: PMC2136661          DOI: 10.1084/jem.104.2.183

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  11 in total

1.  A modified ninhydrin reagent for the photometric determination of amino acids and related compounds.

Authors:  S MOORE; W H STEIN
Journal:  J Biol Chem       Date:  1954-12       Impact factor: 5.157

2.  A method of assaying small amounts of hypertensin.

Authors:  L T SKEGGS; J R KAHN; W H MARSH
Journal:  Lab Invest       Date:  1953 Mar-Apr       Impact factor: 5.662

3.  Chromatography of amino acids on sulfonated polystyrene resins.

Authors:  S MOORE; W H STEIN
Journal:  J Biol Chem       Date:  1951-10       Impact factor: 5.157

4.  The preparation and function of the hypertensin-converting enzyme.

Authors:  L T SKEGGS; J R KAHN; N P SHUMWAY
Journal:  J Exp Med       Date:  1956-03-01       Impact factor: 14.307

5.  The isolation and assay of hypertensin from blood.

Authors:  L T SKEGGS; J R KAHN; N P SHUMWAY
Journal:  J Exp Med       Date:  1952-03       Impact factor: 14.307

6.  The purification of hypertensin II.

Authors:  L T SKEGGS; J R KAHN; N P SHUMWAY
Journal:  J Exp Med       Date:  1956-03-01       Impact factor: 14.307

7.  The purification of hypertensin I.

Authors:  L T SKEGGS; W H MARSH; J R KAHN; N P SHUMWAY
Journal:  J Exp Med       Date:  1954-10-01       Impact factor: 14.307

8.  The existence of two forms of hypertensin.

Authors:  L T SKEGGS; W H MARSH; J R KAHN; N P SHUMWAY
Journal:  J Exp Med       Date:  1954-03       Impact factor: 14.307

9.  Amino acid composition and electrophoretic properties of hypertensin I.

Authors:  L T SKEGGS; W H MARSH; J R KAHN; N P SHUMWAY
Journal:  J Exp Med       Date:  1955-10-01       Impact factor: 14.307

10.  The assay of hypertensin from the arterial blood of normotensive and hypertensive human beings.

Authors:  J R KAHN; L T SKEGGS; N P SHUMWAY; P E WISENBAUGH
Journal:  J Exp Med       Date:  1952-06       Impact factor: 14.307

View more
  23 in total

1.  [Studies on serum angiotensinase. II. Clinical results in hypertension and liver diseases].

Authors:  D KLAUS; H KAFFARNIK; H PFEIL
Journal:  Klin Wochenschr       Date:  1963-04-15

2.  A COMPARISON OF ANGIOTENSIN AND BRADYKININ.

Authors:  G P LEWIS
Journal:  Can Med Assoc J       Date:  1964-01-25       Impact factor: 8.262

3.  [Renin and hypertension, physiological or pathological agents?].

Authors:  F GROSS
Journal:  Klin Wochenschr       Date:  1958-08-01

4.  Isolation and identification of a pepsitensin.

Authors:  M T De Fernández; A C Paladini; A E Delius
Journal:  Biochem J       Date:  1965-11       Impact factor: 3.857

5.  Hypertension symposium: newer topics on normal and abnormal blood pressure regulatory mechanisms.

Authors:  M L Tuck; M S Golub; P Eggena; J R Sowers; M Maxwell
Journal:  West J Med       Date:  1983-08

Review 6.  Biological and biochemical properties of angiotensin-converting enzyme.

Authors:  R L Soffer; M Das; P R Caldwell; B C Seegal; K C Hsu
Journal:  Agents Actions       Date:  1976-07

7.  Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm.

Authors:  N Benjamin; J R Cockcroft; J G Collier; C T Dollery; J M Ritter; D J Webb
Journal:  J Physiol       Date:  1989-05       Impact factor: 5.182

8.  Reversal of renovascular hypertension by antibodies specific for angiotensin-converting enzyme.

Authors:  R A Markle; E H Sonnenblick; J M Conroy; R L Soffer
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

Review 9.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

10.  Lack of effect of enalaprilat on the action of vasoactive intestinal polypeptide in the human forearm.

Authors:  J R Cockcroft; P Chowienczyk; T G Elliott; J M Ritter
Journal:  Br J Clin Pharmacol       Date:  1993-05       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.